Things often seem either black or white within the targeted protein degradation (TPD) space. The biology behind degrading therapeutic targets that are difficult or dangerous to inhibit is well ...

Hainan Simcere Pharmaceutical Co. Ltd. has synthesized protein degradation inducers comprising a regulator and/or promoter of protein proteasomal degradation moiety covalently linked to a protein ...

Lycia Therapeutics Inc. has reported progress in its immunology pipeline that comprises lysosomal targeting chimera (LYTAC)-based protein degradation therapies. The company is advancing its two lead ...